Lumos Diagnostics Holdings Ltd

ASX:LDX (USA)   Ordinary Shares
A$ 0.05 (0%) May 10
At Loss
P/B:
1.75
Market Cap:
A$ 24.07M ($ 15.94M)
Enterprise V:
A$ 34.93M ($ 23.14M)
Volume:
416.03K
Avg Vol (2M):
2.33M
Also Trade In:
Volume:
416.03K
At Loss
Avg Vol (2M):
2.33M

Business Description

Lumos Diagnostics Holdings Ltd

ISIN : AU0000157091

Share Class Description:

ASX:LDX: Ordinary Shares
Description
Lumos Diagnostics Holdings Ltd is engaged in the development, manufacture and distribution of point-of-care diagnostic (POC) tests and associated readers for analysis of POC diagnostic tests. It also directly develops, manufactures and commercializes proprietary, Lumos-branded POC tests that target infectious and inflammatory diseases. It generates maximum revenue from the commercial services and solutions relating to POC diagnostic tests.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.16
Equity-to-Asset 0.4
Debt-to-Equity 0.92
Debt-to-EBITDA -1.72
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 34.2
9-Day RSI 33.66
14-Day RSI 34.36
6-1 Month Momentum % -6.85
12-1 Month Momentum % 257.89

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.69
Quick Ratio 0.48
Cash Ratio 0.22
Days Inventory 147.26
Days Sales Outstanding 94.27
Days Payable 267.89

Dividend & Buy Back

Name Current Vs Industry Vs History

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % 59.72
Operating Margin % -113.49
Net Margin % -107.49
FCF Margin % -105.84
ROE % -89.57
ROA % -36.11
ROIC % -38.35
ROC (Joel Greenblatt) % -96.5
ROCE % -47.89

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 1.27
PB Ratio 1.75
EV-to-EBIT -3.03
EV-to-EBITDA -4.79
EV-to-Revenue 2.89
EV-to-FCF -2.8
Earnings Yield (Greenblatt) % -32.99
FCF Yield % -52.87

Financials (Next Earnings Date:2024-07-19 Est.)

ASX:LDX's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Lumos Diagnostics Holdings Ltd Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil A$) 12.25
EPS (TTM) (A$) -0.032
Beta 0
Volatility % 431.61
14-Day RSI 34.36
14-Day ATR (A$) 0.002976
20-Day SMA (A$) 0.054
12-1 Month Momentum % 257.89
52-Week Range (A$) 0.01 - 0.175
Shares Outstanding (Mil) 481.31

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Lumos Diagnostics Holdings Ltd Filings

Filing Date Document Date Form
No Filing Data

Lumos Diagnostics Holdings Ltd Stock Events

Financials Calendars
Event Date Price(A$)
No Event Data

Lumos Diagnostics Holdings Ltd Frequently Asked Questions

What is Lumos Diagnostics Holdings Ltd(ASX:LDX)'s stock price today?
The current price of ASX:LDX is A$0.05. The 52 week high of ASX:LDX is A$0.18 and 52 week low is A$0.01.
When is next earnings date of Lumos Diagnostics Holdings Ltd(ASX:LDX)?
The next earnings date of Lumos Diagnostics Holdings Ltd(ASX:LDX) is 2024-07-19 Est..
Does Lumos Diagnostics Holdings Ltd(ASX:LDX) pay dividends? If so, how much?
Lumos Diagnostics Holdings Ltd(ASX:LDX) does not pay dividend.

Press Release

Subject Date
No Press Release